Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabricated cell islands

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Wang, Kevin ^a   Wang, Joanne H ^b   Baskaran, Harihara ^c   Wang, Russell ^d   Jurevic, Rick ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c Case Western Reserve University   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cancer cell migration; Head and neck cancer; Human beta defensin; Micro fabricated cell islands; Migration index

Indexed keywords

BETA DEFENSIN 3; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTECHNOLOGY; PRIORITY JOURNAL;

BETA-DEFENSINS; CELL MOVEMENT; CYTOLOGICAL TECHNIQUES; EPITHELIAL CELLS; HEAD AND NECK NEOPLASMS; HEK293 CELLS; HUMANS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862760933     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-41     Document Type: Article

References (20)

1. Cancer Facts and Figures 2011 American Cancer Society. October, Atlanta 2011
2. Brodt P, Cell adhesion and invasion in cancer metastasis Chapman & Hal, New York 1996
3. Regulation of cancer cell migration and bone metastasis by RANKL. Jones D, Nakashima T, Sanchez O, et al. Nature 2006 440 692 696 10.1038/nature04524 16572175
4. Beta-defensins: what are they REALLY doing in the oral cavity? Diamond G, Ryan LK, Oral Dis 2011 17 628 635 10.1111/j.1601-0825.2011.01799.x 21332602
5. Detection of -defensins secreted by human oral epithelial cells. Diamond G, Kimball J, Krisanaprakornki S, Dale B, J Immune Meth 2001 256 65 76 10.1016/S0022-1759(01)00442-2
6. Cancer specific loss of beta-defensin 1 in renal and prostatic carcinomas. Donald CD, Sun CQ, Lim SD, et al. Lab Invest 2003 83 501 505 12695553
7. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Young AN, Salles PG, Lim SD, et al. Am J Surg Pathol 2003 27 199 205 10.1097/00000478-200302000-00008 12548166
8. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. Gambichler T, Skrygan M, Huyn J, et al. BMC Cancer 2006 6 163 168 10.1186/1471-2407-6-163 16796735
9. Loss of human -definsin 1, 2, and 3 expression in oral squamous cell carcinoma. Joly S, Compton LM, Pujol C, Kurago ZB, et al. Oral Micro Immun 2009 24 353 360 10.1111/j.1399-302X.2009.00512.x
10. Molecular classification of renal tumors by gene expression profiling. Schultz AN, Yin-Goen Q, Amin MB, J Mol Diagn 2005 7 206 218 10.1016/S1525- 1578(10)60547-8 15858144
11. Elevated serum beta-defensins concentrations in patients with lung cancer. Arimura Y, Ashitani J, Yanagi S, Anticancer Res 2004 24 4051 4057 15736451
12. Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulval tumors. Shnitsar VM, Lisovskiy IL, Soldatkina MA, et al. Exp Oncol 2004 26 328 330 15627069
13. High concentration of beta-defensin 2 in oral squamous cell carcinoma. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, et al. Anticancer Res 2002 22 2103 2107 12174890
14. Expression of -defensins in gingival health and in periodontal disease. Bissell J, Joly S, Johnson GK, et al. J Oral Pathol Med 2004 33 278 285 10.1111/j.0904-2512.2004.00143.x 15078488
15. Overexpression of human -Defensin 3 in oral dysplasia: Potential role in macrophage trafficking. Kawar HI, Weinberg A, Hirsh S, et al. Oral Oncol 2009 45 12 19
16. Matrigel: basement membrane matrix with biological activity. Kleinman HK, Martin GR, Semin Cancer Biol 2005 15 378 386 10.1016/j.semcancer.2005.05.004 15975825
17. From micro- to nanofabrication with soft materials in nanotechnology. Quake SR, Scherer A, Science 2004 290 1536 1540
18. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Eicher SA, Clayman GL, Liu TJ, Shillitoe EJ, et al. Clin Cancer Res 1996 10 1659 1664
19. Quantification of human beta-defensin-2 and 3 in body fluids: application for studies of innate immunity. Ghosh SK, Gerken TA, Schneider KM, Feng Z, et al. Clin Chem 2007 53 757 765 10.1373/clinchem.2006.081430 17317882
20. Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients. Amo Y, Masuzawa M, Hamada Y, Katsuoka K, Br J Dermatol 2004 150 160 163 10.1111/j.1365-2133.2004.05751.x 14746640